<DOC>
	<DOCNO>NCT02803086</DOCNO>
	<brief_summary>The prophylactic irradiation pelvic lymph-nodes mean Whole-Pelvis Radiotherapy ( WPRT ) treatment prostate cancer ( PCa ) aim timely eradication microscopic lymph-nodal metastasis . Nevertheless , even though deliver mean modern Intensity-Modulated Radiotherapy ( IMRT ) technique , WPRT may result intestinal , hematologic urinary toxicity ( IT , HT , UT , respectively ) severely affect patient ' daily health-related quality-of-life ( HRQoL ) within so-called inadequately investigated Pelvic Radiation Disease . The aim study develop sophisticated predictive model IMRT-WPRT induce patient-reported HT , IT UT PCa . The possible correlation several clinical factor radiation dose receive various pelvic structure ( i.e . pelvic bone subvolumes , intestinal loop , sigmoid , rectum bladder ) risk severity patient-reported IT , UT HT analyze robust multi-variable model develop internally validate . A secondary end-point identification specific symptom affect patient ' HRQoL irradiation long term , overall different therapeutic setting ( radical , adjuvant salvage ) . Lastly , possible correlation HT UT/IT investigate .</brief_summary>
	<brief_title>Longitudinal Evaluation Intestinal , Haematological Urinary Toxicity From Pelvic Irradiation Prostate Cancer</brief_title>
	<detailed_description>Experimental Design : Hypothesis . Dose-volume histogram ( DVHs ) bowel , sigmoid colon rectum expect predictive IT prospectively self-assessed patient mean IBDQ ( Inflammatory Bowel Disease Questionnaire ) . Similarly , DVHs pelvic bony subvolumes ( lumbar-sacral , iliac low pelvis ) predict HT , DVHs dose-surface histogram ( DSHs ) bladder expect predictive UT self-assessed patient mean IPSS ( International Prostate Symptoms Score ) ICIQ-SF ( International Consultation Incontinence Questionnaire- short form ) questionnaires . Moreover , specific urinary intestinal-rectal symptom expect lead impairment emotional , social systemic domain , assess IBDQ questionnaire , others , several possible `` cluster '' symptom prevail different treatment setting . Finally , intestinal , urinary hematologic toxicity profile WPRT IMRT could emerge extremely different patient treat radical ( RAD ) , adjuvant ( ADV ) salvage ( SALV ) intent . Task1 . The principal aim project develop sophisticated quantitative predictive model IT , UT HT ( without confound bias chemotherapy ) WPRT IMRT radical postoperative treatment localize PCa . The possible correlation radiation dose receive different pelvic structure different toxicity analyze . Task2 . To try individuate intestinal/rectal urinary symptom negatively affect Emotional , Social Systemic patient domain , ultimate objective `` focusing '' quantitative predictive model include clinical physico-dosimetric parameter upon main symptom . This approach could theoretically permit creation `` shorten radiotherapy adapt '' version IBDQ questionnaire . Task3 . A thorough assessment different self-assessed toxicity profile expect patient treat RAD , ADV SALV intent carry , ultimate aim accumulate set extremely detailed information provide patient order offer appropriate counsel initial diagnosis PCa regard choice radiotherapy v surgery . In select latter presence risk factor prostatectomy suggest possible role postoperative radiotherapy , ultimate objective would assist patient always extremely problematic choice immediate adjuvant timely , postpone , salvage irradiation case biochemical recurrence . Task4 . Secondary end-points : search possible correlation HT IT/UT . Throughout treatment period , patient see every 2 week toxicity monitoring . Subsequently , follow-up visit perform 3 month end treatment , every six month thereafter , 5 year . Intestinal urinary toxicity , include urinary incontinence , self-assessed patient mean Italian validate version IBDQ , IPSS ICIQ-SF questionnaire : baseline ( 30 day RT start ) , radiotherapy mid-point end , 3 , 6,12 , 18 , 24 , 30 , 36 , 42 , 48 , 54 60 month radiotherapy conclusion . A blood sample white blood cell ( WBC ) , absolute neutrophil lymphocyte count ( ANC ALC , respectively ) , red blood cell ( RBC ) platelet ( PLT ) count collected time interval . In addition self-reported assessment rectal/bowel urinary symptom radiotherapy , evaluation acute late IT UT perform medical staff possible future comparison subjective objective measurement . IT , HT UT grade accord Common Terminology Criteria Adverse Events ( CTCAE ) v4.03 .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>Patients ECOG PS 01 Patients histologically proven adenocarcinoma prostate WPRT deliver static rotational IMRT technique volumetric modulate arc therapy ( VMAT ) Tomotherapy Both conventionally ( 1.82 Gy/fraction ) moderately hypofractionated ( â‰¤ 2.7 Gy/fraction ) regimens simultaneous integrate boost ( SIB ) approach allow ; case daily dose deliver pelvic node range 1.82.0 Gy/fr Patients old 80 year time enrollment Missing write informed consent</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Prostate cancer</keyword>
	<keyword>Radiotherapy</keyword>
	<keyword>Hematopoietic stem cell</keyword>
	<keyword>Radiotoxicity</keyword>
</DOC>